This study investigates the treatment of locally advanced pancreatic cancer. It involves a combination of therapies including medication and radiation.
The study evaluates the safety and effectiveness of these combined treatments in managing the condition.
- Who can participate: Adults aged 18 to 75 with locally advanced pancreatic cancer may participate. Key criteria include specific health measurements and no history of autoimmune disease.
- Study details: Participants will receive a combination of therapies including an investigational medication and radiation therapy.